Apnimed, Inc. (APMD)
14.46
+0.30
(+2.12%)
USD |
NASDAQ |
Nov 06, 10:25
Apnimed Net Income (Quarterly) : 126.11M for June 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 126.11M |
| March 31, 2026 | 70.37M |
| Date | Value |
|---|---|
| June 30, 2025 | -5.627M |
| March 31, 2025 | -26.68M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| IGC Pharma, Inc. | -2.936M |
| Cocrystal Pharma, Inc. | -3.164M |
| CNBX Pharmaceuticals, Inc. | -0.1542M |
| Arvinas, Inc. | -53.90M |
| Fulcrum Therapeutics, Inc. | -26.18M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 12.08M |
| Total Expenses (Quarterly) | -114.03M |
| EPS Diluted (Quarterly) | 3.025 |
| Enterprise Value | 742.98M |
| Gross Profit Margin (Quarterly) | 89.98% |
| Earnings Yield | 16.16% |
| Operating Earnings Yield | 3.96% |
| Normalized Earnings Yield | 16.38 |